Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PURE Relative to the S&P 500

PURE Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Pure Bioscience (OTCMKT:PURE) seasonal charts above shows that a Buy Date of July 29 and a Sell Date of October 27 has resulted in a geometric average return of 4.7% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 34.69% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Consumer Staples sector, which runs from April 25 to November 23. The seasonal chart for the broad sector is available via the following link: Consumer Staples Sector Seasonal Chart.

PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.

To download PURE seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PURE